(S (S (NP (NP (NNP Breast) (NN cancer)) (PRN (-LRB- -LRB-) (NP (NNP BC)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (NN cancer)) (PP (IN among) (NP (NNS women))) (ADVP (RB world-wide))))) (, ,) (S (NP (NP (QP (RB approximately) (JJ 20-25)) (NN %)) (PP (IN of) (NP (NNP BCs)))) (VP (VBP are) (ADJP (NNP HER-2) (JJ positive)))) (. .))
(S (NP (NP (NN Analysis)) (PP (IN of) (NP (NNP HER-2)))) (VP (VBZ is) (ADJP (JJ fundamental) (PP (TO to) (S (VP (VBG defining) (NP (NP (DT the) (JJ appropriate) (NN therapy)) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ breast) (NN cancer))))))))))) (. .))
(S (NP (NP (JJ Inter-pathologist) (NN variability)) (PP (IN in) (NP (DT the) (NN test) (NNS results)))) (VP (MD can) (VP (VB affect) (NP (JJ diagnostic) (NN accuracy)))) (. .))
(S (NP (DT The) (JJ present) (NN study)) (VP (VBZ intends) (S (VP (TO to) (VP (VB propose) (NP (DT an) (JJ automatic) (NN scoring) (NNP HER-2) (NN algorithm)))))) (. .))
(S (PP (VBN Based) (PP (IN on) (NP (NN color) (NNS features)))) (, ,) (NP (DT the) (NN technique)) (VP (VP (VBZ is) (ADJP (JJ fully-automated))) (CC and) (VP (JJ avoids) (NP (NN segmentation))) (, ,) (S (VP (VBG showing) (NP (NP (DT a) (NN concordance)) (ADJP (ADJP (JJR higher)) (PP (IN than) (NP (CD 90) (NN %)))) (PP (IN with) (NP (DT a) (NN pathologist)))) (PP (IN in) (NP (NP (DT the) (NNS experiments)) (VP (VBN realized))))))) (. .))
